Form 4: Idexx Laboratories Director Sophie V. Vandebroek Reports Stock Transactions
SEC Form 4 Filing
Director Sophie V. Vandebroek reports the exercise of stock options and subsequent sale of shares in Idexx Laboratories.
Summary
- On March 5, 2024, Sophie V. Vandebroek, a director of Idexx Laboratories, exercised non-qualified stock options to acquire 1,404 shares of common stock at a price of $245.79 per share.
- Following the exercise of the options, Ms. Vandebroek sold 1,404 shares of common stock at a weighted average price of $562.9822 per share.
- After these transactions, Ms. Vandebroek directly owns 1,216 shares of Idexx Laboratories common stock and indirectly owns 8,173 shares through the Sophie V. Vandebroek Revocable Trust.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing stock transactions. It doesn't inherently convey positive or negative sentiment.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common occurrence in publicly traded companies. It provides transparency into the trading activities of key personnel.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership by a company director.
Key Dates
| Date | Description |
|---|---|
| 05/06/2020 | Grant of option to buy shares of IDEXX Laboratories, Inc. common stock that vested in one installment. |
| 05/07/2029 | Expiration date of the Non-Qualified Stock Option. |
| 03/05/2024 | Date of transaction: exercise of stock options and sale of shares. |
| 03/07/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.